Thailand's king recovering after respiratory infection: palace
- Noble Energy (NBL) to Acquire Clayton Williams Energy (CWEI) for $2.7B in Cash and Stock
- Nasdaq hits record; bank earnings validate Wall St. rally
- Intrawest Resorts (SNOW) Exploring a Possible Sale - Reuters
- Alibaba (BABA) Has No Plans to Acquire Rest of Groupon (GRPN) - Source
- Time (TIME) Said to Soon Begin Discussions with Interested Buyers - Bloomberg
Thailand's King Bhumibol Adulyadej is seen attending a ceremony in Bangkok, Thailand December 14, 2015 in this still image taken from Thai TV Pool video. REUTERS/Thai TV Pool
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
BANGKOK (Reuters) - Thailand's 88-year-old King Bhumibol Adulyadej, the world's longest reigning monarch, is recovering after a respiratory infection, the palace said in a statement on Saturday.
The king has no fever and is breathing normally after doctors administered antibiotics to treat an inflammation of his left lung on Sep. 29, it said.
A team of physicians would continue to give the king renal therapy and monitor his condition closely, it added.
Saturday's statement comes after four health updates in September.
The king has been treated for various ailments during a year-long hospitalization in the Thai capital.
King Bhumibol is deeply revered in Thailand where he is accorded semi-divine status. Many Thais see him as a pillar of stability in a country subject to bouts of political instability and which has been ruled by a military junta since 2014.
The king was last seen in public on January 11.
(Reporting by Pairat Temphairojana; Editing by Andrew R.C. Marshall and Alexander Smith)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oil prices inch up on Saudi commitment to cut output
- Canada's Portag3 Ventures invests in Street Contxt
- Cuba, United States to fight terrorism, drug trafficking and other crimes
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!